Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
U.S. needs to pursue evidence-based interventions for substance use disorders. It’s unclear to what degree the Trump ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
Mexican President Claudia Sheinbaum Pardo rejected the “White House's slander” against her government after Donald Trump's tariff order.
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...
Trump signed three executive orders late Saturday afternoon at his Mar-a-Lago resort in Florida, launching the salvoes. Layered on top of those already in place, the tariffs will ...
The US Food and Drug Administration (FDA) has approved a new pain medication, suzetrigine, marking the first new type of pain reliever to be approved in over 20 years.The drug, sold under the brand ...